FDA Warns California OTC Drugmaker for Defective Products By Sam | March 29, 2019 The FDA issued a warning letter to Thibiant International for producing defective OTC drugs at its Newbury Park, California manufacturing facility. Source: Drug Industry Daily Posted in Drug Industry Daily